J, P., MQ, L., V, J., P, R., C, S., E, H., . . . C, C. (2024). GLP-1-directed NMDA receptor antagonism for obesity treatment. Nature, 629(8014), 1133. https://doi.org/10.1038/s41586-024-07419-8
Chicago Style (17th ed.) CitationJ, Petersen, et al. "GLP-1-directed NMDA Receptor Antagonism for Obesity Treatment." Nature 629, no. 8014 (2024): 1133. https://doi.org/10.1038/s41586-024-07419-8.
MLA (9th ed.) CitationJ, Petersen, et al. "GLP-1-directed NMDA Receptor Antagonism for Obesity Treatment." Nature, vol. 629, no. 8014, 2024, p. 1133, https://doi.org/10.1038/s41586-024-07419-8.
Warning: These citations may not always be 100% accurate.